Laboratory Animal Resources Center, Department of Biomaterials Science (BK21 FOUR Program), Life and Industry Convergence Research Institute, College of Natural Resources & Life Science, Pusan National University, Miryang 50463, Korea.
Department of Food Science and Nutrition, College of Human Ecology, Pusan National University, Busan 46241, Korea.
Molecules. 2021 Nov 28;26(23):7209. doi: 10.3390/molecules26237209.
This study investigated the laxative effects of phlorotannins (Pt) derived from () on chronic constipation by evaluating alterations in stool parameters, gastrointestinal motility, histopathological structure, mucin secretion, gastrointestinal hormones, muscarinic cholinergic regulation, and fecal microbiota in SD rats with loperamide (Lop)-induced constipation subjected to Pt treatment. Stool-related parameters (including stool number, weight, and water contents), gastrointestinal motility, and length of intestine were significantly enhanced in the Lop+Pt-treated group as compared to the Lop+Vehicle-treated group. A similar recovery was detected in the histopathological and cytological structure of the mid-colon of Lop+Pt-treated rats, although the level of mucin secretion remained constant. Moreover, rats with Lop-induced constipation subjected to Pt treatment showed significant improvements in water channel expression, gastrointestinal hormone secretions, and expression of muscarinic acetylcholine receptors M2/M3 (mAChRs M2/M3) and their mediators of muscarinic cholinergic regulation. Furthermore, the Lop+Pt-treated group showed a significant recovery of , , , and families in fecal microbiota. Taken together, these results provide the first evidence that exposure of SD rats with Lop-induced constipation to Pt improves the constipation phenotype through the regulation of membrane water channel expression, GI hormones, the mAChR signaling pathway, and fecal microbiota.
本研究通过评估粪便参数、胃肠道动力、组织病理学结构、黏蛋白分泌、胃肠激素、毒蕈碱型胆碱能调节以及给予洛哌丁胺(Lop)诱导便秘的 SD 大鼠接受 Phlorotannins(Pt)治疗后的粪便微生物群的变化,研究了来自()的 Phlorotannins(Pt)对慢性便秘的通便作用。与洛哌丁胺+载体组相比,洛哌丁胺+Pt 治疗组的粪便相关参数(包括粪便数量、重量和水分含量)、胃肠道动力和肠长度均显著增加。尽管黏蛋白分泌保持不变,但洛哌丁胺+Pt 治疗大鼠的中结肠组织学和细胞学结构也出现了类似的恢复。此外,接受洛哌丁胺诱导的便秘的大鼠在水通道表达、胃肠激素分泌以及毒蕈碱型乙酰胆碱受体 M2/M3(mAChR M2/M3)及其毒蕈碱型胆碱能调节介质的表达方面均有显著改善。此外,洛哌丁胺+Pt 治疗组粪便微生物群中的 、 、 和 家族也得到了显著恢复。总之,这些结果首次提供了证据,表明暴露于洛哌丁胺诱导的便秘的 SD 大鼠接受 Pt 治疗可通过调节膜水通道表达、GI 激素、mAChR 信号通路和粪便微生物群来改善便秘表型。